Events | 2022.10.10
uMotif to Showcase How Transformative eCOA/ePRO Technology Enables Faster, More Engaging Trials and Real-World Studies at Premier Pharma and Biotech Industry Events
Executives including CEO Steve Rosenberg, Co-Founder & Chief Patient Officer Bruce Hellman to discuss the eCOA/ePRO market – what’s working, what’s wrong, and what patients need now
(PRWeb October 10, 2022)
Read the full story at https://www.prweb.com/releases/2022/10/prweb18947430.htm
For more information, please visit
https://www.prweb.com/releases/2022/10/prweb18947430.htm
